SYMPOSIA ABSTRACTS
Symposia Session XXXII
S-32 RECENT DEVELOPMENT IN THE
PHARMACOLOGY OF GLUTAMATE
| S-32/1 | Neurotensin
receptor as modulator of glutamate transmission in the brain: relevance for
neurodegenerative diseases L. Ferraro, T. Antonelli, M.C. Tomasini, S. Beggiato, S. Tanganelli (Ferrara) |
| S-32/2 | Regulation of
mGlu 5 receptor activity by the endocannabinoid system V. De Chiara, S. Rossi, A. Musella, V. Studer, C. Motta, G. Bernardi, A. Usiello, M. Maccarrone, D. Centonze (Roma, Napoli) |
| S-32/3 | The impact of
behavioral stress and antidepressant/anxiolytic treatments on glutamate
transmission: relevance for neuropsychiatric disorders G. Treccani, L. Musazzi, M. Milanese, C. Perego, A. Villa, A. Corbelli, G. Racagni, G. Bonanno, M. Popoli (Milano, Genova, Monza) |
| S-32/4 | Abnormal
glutamate exocytosis: a possible cause of excyotoxicy in ALS M. Milanese, T. Bonifacino, F. Onofri, L. Musazzi, F. Giribaldi, A. Puliti, F. Benfenati, M. Popoli, G. Bonanno (Genova, Milano) |
| S-32/5 | Soluble beta amyloid exposure and glutamatergic dysregulation:
investigating the link L. Trabace, V. Cuomo (Foggia, Roma) |